Follow-up of patients with chronic conditions within primary care practices during COVID-19: Results from 7 Central and Eastern-European countries from the cross-sectional PRICOV-19 study.
COVID-19
Patient follow-up
multi-country
outreach
quality of care
Journal
The European journal of general practice
ISSN: 1751-1402
Titre abrégé: Eur J Gen Pract
Pays: England
ID NLM: 9513566
Informations de publication
Date de publication:
Dec 2024
Dec 2024
Historique:
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
29
8
2024
Statut:
ppublish
Résumé
The COVID-19 pandemic posed severe challenges to delivery of services at Primary Care level and for achieving follow-up of patients with chronic diseases. We analysed data from the PRICOV-19 study to explore determinants of active follow-up for chronic disease patients in seven Central and Eastern European (CEE) countries during the pandemic. Pricov-19 was a cross-sectional study conducted within PC (Primary Care) practices in 37 European countries. We analysed data from 7 CEE countries (Bulgaria, Czech Republic, Hungary, Poland, Moldova, Romania, Ukraine) collected between November 2020 and December 2021. Practices were recruited through random or convenience sampling and participation of practices was voluntary. We performed descriptive statistics to identify the level of follow-up of chronic disease and what health system and practice-specific factors were associated with better follow-up. We used logistic regression and meta-analysis techniques to explore associations and heterogeneity between countries. 67.8% out of 978 practices reported actively following up chronic patients. Positive associations were found between active follow-up and such as having more GPs (aOR = 1.18, p-value = 0.005), an above-average chronic patient population (aOR = 3.13, p-value = 0.006), adequate government support (aOR = 2.35, p-value = 0.001), and GPs having time for guideline reading (aOR = 0.008, p-value = 1.71). Patient follow-up, was influenced by different health system and practice-specific factors. The implications suggest the need for government support to enhance PC practice organisation during crises and solutions to decrease GP workload and provide tailored care for patients with chronic disease. In 7 Central and Eastern European countries, 68% of PC practices effectively followed-up patients with chronic conditions during the pandemic.Key determinants for successful follow-up included government support, GP time availability, and staffing levels of GPs.Video consultations and payment mechanisms did not show significant associations with optimal patient follow-up.
Sections du résumé
BACKGROUND
UNASSIGNED
The COVID-19 pandemic posed severe challenges to delivery of services at Primary Care level and for achieving follow-up of patients with chronic diseases.
OBJECTIVES
UNASSIGNED
We analysed data from the PRICOV-19 study to explore determinants of active follow-up for chronic disease patients in seven Central and Eastern European (CEE) countries during the pandemic.
METHODS
UNASSIGNED
Pricov-19 was a cross-sectional study conducted within PC (Primary Care) practices in 37 European countries. We analysed data from 7 CEE countries (Bulgaria, Czech Republic, Hungary, Poland, Moldova, Romania, Ukraine) collected between November 2020 and December 2021. Practices were recruited through random or convenience sampling and participation of practices was voluntary. We performed descriptive statistics to identify the level of follow-up of chronic disease and what health system and practice-specific factors were associated with better follow-up. We used logistic regression and meta-analysis techniques to explore associations and heterogeneity between countries.
RESULTS
UNASSIGNED
67.8% out of 978 practices reported actively following up chronic patients. Positive associations were found between active follow-up and such as having more GPs (aOR = 1.18, p-value = 0.005), an above-average chronic patient population (aOR = 3.13, p-value = 0.006), adequate government support (aOR = 2.35, p-value = 0.001), and GPs having time for guideline reading (aOR = 0.008, p-value = 1.71).
CONCLUSIONS
UNASSIGNED
Patient follow-up, was influenced by different health system and practice-specific factors. The implications suggest the need for government support to enhance PC practice organisation during crises and solutions to decrease GP workload and provide tailored care for patients with chronic disease.
In 7 Central and Eastern European countries, 68% of PC practices effectively followed-up patients with chronic conditions during the pandemic.Key determinants for successful follow-up included government support, GP time availability, and staffing levels of GPs.Video consultations and payment mechanisms did not show significant associations with optimal patient follow-up.
Autres résumés
Type: plain-language-summary
(eng)
In 7 Central and Eastern European countries, 68% of PC practices effectively followed-up patients with chronic conditions during the pandemic.Key determinants for successful follow-up included government support, GP time availability, and staffing levels of GPs.Video consultations and payment mechanisms did not show significant associations with optimal patient follow-up.
Identifiants
pubmed: 39207040
doi: 10.1080/13814788.2024.2391468
pmc: PMC11363735
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2391468Références
Health Econ Rev. 2022 Feb 12;12(1):14
pubmed: 35150372
Nat Med. 2021 Jun;27(6):964-980
pubmed: 34002090
BMC Prim Care. 2023 Jul 1;24(1):137
pubmed: 37393225
Health Policy Plan. 2021 Aug 12;36(7):1163-1186
pubmed: 34185844
PLoS One. 2021 Mar 4;16(3):e0247461
pubmed: 33661992
Fam Pract. 2008 Apr;25(2):113-8
pubmed: 18304970
Int J Physiol Pathophysiol Pharmacol. 2021 Jun 15;13(3):86-93
pubmed: 34336132
BJGP Open. 2023 Jun 27;7(2):
pubmed: 36849167
JAMA Netw Open. 2020 Oct 1;3(10):e2021476
pubmed: 33006622
Health Policy. 2018 Oct;122(10):1070-1077
pubmed: 30041912
BMC Prim Care. 2022 Apr 18;23(1):82
pubmed: 35436865
J Med Internet Res. 2021 Sep 14;23(9):e29622
pubmed: 34313600
BMC Prim Care. 2022 Jan 15;23(1):11
pubmed: 35172744
Health Policy. 2022 May;126(5):391-397
pubmed: 34489126
J Cancer Surviv. 2016 Dec;10(6):990-1011
pubmed: 27138994
Soc Sci Med. 2022 Apr;298:114858
pubmed: 35247784
Int J Environ Res Public Health. 2023 Feb 10;20(4):
pubmed: 36833862
Eur J Nutr. 2021 Mar;60(2):1091-1100
pubmed: 32613328
BMC Fam Pract. 2012 Mar 12;13:15
pubmed: 22409775
Front Public Health. 2023 Jan 16;10:1082164
pubmed: 36726627
Lancet. 2020 May 30;395(10238):1678-1680
pubmed: 32401713
Int J Med Inform. 2010 Nov;79(11):736-71
pubmed: 20884286
BMC Fam Pract. 2013 Mar 19;14:37
pubmed: 23510461